Skip to main content
. 2013 Feb 4;12:9. doi: 10.1186/1476-511X-12-9

Figure 2.

Figure 2

Changes in lipid profiles between baseline and 4, 8 and 12 weeks after randomization. HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; T-Cho, total cholesterol; TG, triglycerides. *p < 0.05 versus rosuvastatin 2.5 mg/day + ezetimibe 10 mg/day.